Opendata, web and dolomites

PLATOSCIENCE SIGNED

Personalized Neurostimulation Approach for the Treatment of Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLATOSCIENCE project word cloud

Explore the words cloud of the PLATOSCIENCE project. It provides you a very rough idea of what is the project "PLATOSCIENCE" about.

neuroimaging    despite    trans    headset    individual    severe    jobs    solutions    clear    create    segment    depressions    yielding    customized    setting    tracked    acknowledge    plug    costing    clinics    yields    18    direct    collection    acute    predictive    validation    medication    start    programmable    million    2005    worldwide    neurostimulation    market    electroencephalogram    profit    app    nor    moderate    patients    hospitals    clinical    options    conventional    measuring    connected    treatment    standard    ph1    first    stimulation    professionals    subject    patent    benefits    revenue    25    analytics    protected    establishing    regulatory    platoscience    until    patient    2026    personalised    world    300    online    efficient    group    people    play    rehabilitation    sme    cloud    electrophysiological    consists    home    tdcs    eeg    commercialisation    health    electrodes    2015    international    cranial    device    depression    portable    competition    hereafter    commercialization    stakeholders    170bn    ph    platocure    strategy    qualified    medical    gross    introduction    techniques    relevance    cumulative    advantage    untreated    falling    cognitive    15    data    50   

Project "PLATOSCIENCE" data sheet

The following table provides information about the project.

Coordinator
PLATOSCIENCE APS 

Organization address
address: VESTERBROGADE 26
city: KOBENHAVN
postcode: 1620
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website https://platoscience.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PLATOSCIENCE APS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Depression currently affects more than 300 million people worldwide, that is an increase of over 18% between 2005 and 2015. Moreover, 50% of major depressions are untreated in Europe, costing about €170Bn per year. Despite subject´s relevance, there are not any efficient nor customized treatment options, these falling often within conventional solutions (e.g. cognitive techniques), medication or neurostimulation techniques that do not acknowledge an individual rehabilitation for the patient.

Platoscience has developed the world’s first plug n’ play device based on trans-cranial direct current neurostimulation (tDCS) for a personalised at-home treatment of depression. The patent-protected device, PlatoCure, consists of a portable neurostimulation headset with two programmable electrodes, easy to use and control, connected to an app to be tracked by health professionals and for cloud data collection and predictive analytics to improve individual treatment. PlatoCure also includes online neuroimaging by electroencephalogram (EEG) that enables measuring of electrophysiological data during stimulation. This yields a significant advantage of PlatoCure against competition, strengthening market introduction to become the standard treatment device for moderate to severe depression, yielding benefits for a large group of stakeholders, including patients, medical professionals, hospitals and clinics.

The SME Ph1 will be crucial for: i) establishing partnerships with relevant stakeholders on an international level in the medical segment, ii) setting up a regulatory strategy and iii) developing a clear commercialisation strategy. Hereafter, PlatoScience will be able to start SME Ph 2 focusing on the clinical validation of the device with hospitals and clinics. Until the end of 2026, we expect a cumulative revenue of €10,1 million, gross profit of €8,25 million and to create 15 qualified new jobs, within 5 years of commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLATOSCIENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLATOSCIENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More